{"title":"High-risk patient profiles for ovarian cancer: A new approach using cluster analysis of tumor markers","authors":"Zahra Jamalpour , Somayeh Ghaderi , Mostafa Fathian-Kolahkaj","doi":"10.1016/j.jogoh.2024.102888","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Ovarian cancer remains a leading cause of cancer-related deaths in women. Early detection improves prognosis, but current diagnostic tools still need improvement. We aimed to identify high-risk patient profiles for ovarian cancer using cluster analysis of age and tumor marker data.</div></div><div><h3>Material and methods</h3><div>A secondary dataset analysis was conducted using unsupervised learning techniques. Data were from a University Hospital, originally collected between July 2011 and July 2018 in Taiwan. In total, 349 women diagnosed with ovarian masses, including both benign and malignant tumors, were included in this analysis. The median age was 45 years, and 49 % were diagnosed with ovarian cancer in pathology. We used a hierarchical clustering algorithm to find groups of patients with similar features.</div></div><div><h3>Results</h3><div>Two clusters were identified (<em>N</em> = 204 and 145), with a high-risk cluster (66.2 % malignancy) characterized by significantly older age, higher CA125, HE4, CEA, and AFP levels, and a lower CA19–9 level than the low-risk cluster (24.8 % malignancy). The assessment of clustering stability and internal validity yielded a figure of merit score of 0.970 and a silhouette coefficient of 0.524. A classification model using age, CA125, HE4, and CA19–9 demonstrated high accuracy (89.4 %), sensitivity (94.5 %), specificity (83.7 %), and a large area under the curve (89.1 %) for the risk stratification.</div></div><div><h3>Conclusion</h3><div>Integrating tumor markers with patient demographics improved the differentiation between benign and malignant ovarian masses. This approach can help clinicians prioritize high-risk patients for further diagnostic evaluation and reduce unnecessary invasive procedures for low-risk patients.</div></div>","PeriodicalId":15871,"journal":{"name":"Journal of gynecology obstetrics and human reproduction","volume":"54 2","pages":"Article 102888"},"PeriodicalIF":1.7000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of gynecology obstetrics and human reproduction","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468784724001673","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Ovarian cancer remains a leading cause of cancer-related deaths in women. Early detection improves prognosis, but current diagnostic tools still need improvement. We aimed to identify high-risk patient profiles for ovarian cancer using cluster analysis of age and tumor marker data.
Material and methods
A secondary dataset analysis was conducted using unsupervised learning techniques. Data were from a University Hospital, originally collected between July 2011 and July 2018 in Taiwan. In total, 349 women diagnosed with ovarian masses, including both benign and malignant tumors, were included in this analysis. The median age was 45 years, and 49 % were diagnosed with ovarian cancer in pathology. We used a hierarchical clustering algorithm to find groups of patients with similar features.
Results
Two clusters were identified (N = 204 and 145), with a high-risk cluster (66.2 % malignancy) characterized by significantly older age, higher CA125, HE4, CEA, and AFP levels, and a lower CA19–9 level than the low-risk cluster (24.8 % malignancy). The assessment of clustering stability and internal validity yielded a figure of merit score of 0.970 and a silhouette coefficient of 0.524. A classification model using age, CA125, HE4, and CA19–9 demonstrated high accuracy (89.4 %), sensitivity (94.5 %), specificity (83.7 %), and a large area under the curve (89.1 %) for the risk stratification.
Conclusion
Integrating tumor markers with patient demographics improved the differentiation between benign and malignant ovarian masses. This approach can help clinicians prioritize high-risk patients for further diagnostic evaluation and reduce unnecessary invasive procedures for low-risk patients.
期刊介绍:
Formerly known as Journal de Gynécologie Obstétrique et Biologie de la Reproduction, Journal of Gynecology Obstetrics and Human Reproduction is the official Academic publication of the French College of Obstetricians and Gynecologists (Collège National des Gynécologues et Obstétriciens Français / CNGOF).
J Gynecol Obstet Hum Reprod publishes monthly, in English, research papers and techniques in the fields of Gynecology, Obstetrics, Neonatology and Human Reproduction: (guest) editorials, original articles, reviews, updates, technical notes, case reports, letters to the editor and guidelines.
Original works include clinical or laboratory investigations and clinical or equipment reports. Reviews include narrative reviews, systematic reviews and meta-analyses.